A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.

Kui Young ParkHyun Jung KwonJae Min KimGuk Jin JeongBeom Joon KimSeong Jun SeoMyeong Nam Kim

Published in: Annals of dermatology (2018)

Intradermal injection of botulinum toxin can be used as an effective and relatively safe adjuvant agent for recalcitrant and persistent erythema of ETR patients.

Keyphrases

botulinum toxin
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
peritoneal dialysis
ultrasound guided